View in EDS

Adalimumab Drug Levels at Secondary Loss of Response Do Not Predict Response to Dose-intensification in Crohn's Disease: A Retrospective, International Multicenter Study.

Saved in:

Bibliographic Details
Title:	Adalimumab Drug Levels at Secondary Loss of Response Do Not Predict Response to Dose-intensification in Crohn's Disease: A Retrospective, International Multicenter Study.
Authors:	Little RD; Department of Gastroenterology, Alfred Health and Monash University, Melbourne, Australia., Swaine A; Department of Gastroenterology, Redcliffe Hospital, Redcliffe, Australia., Reynolds R; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Gibson DJ; Department of Gastroenterology, Alfred Health and Monash University, Melbourne, Australia., Barrau M; Gastro-entérologie et Hépatologie, Centre Hospitalier Universitaire de Saint-Étienne, Saint-Étienne, France., D'Errico F; Department of Gastroenterology and Endoscopy, Miulli Hospital, Acquaviva delle Fonti, Italy., Hampal R; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Sparrow MP; Department of Gastroenterology, Alfred Health and Monash University, Melbourne, Australia., Roblin X; Gastro-entérologie et Hépatologie, Centre Hospitalier Universitaire de Saint-Étienne, Saint-Étienne, France., Irving PM; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Ward MG; Department of Gastroenterology, Alfred Health and Monash University, Melbourne, Australia.
Source:	Inflammatory bowel diseases [Inflamm Bowel Dis] 2024 Oct 03; Vol. 30 (10), pp. 1714-1723.
Publication Type:	Journal Article; Multicenter Study
Journal Info:	Publisher: Oxford University Press Country of Publication: England NLM ID: 9508162 Publication Model: Print Cited Medium: Internet ISSN: 1536-4844 (Electronic) Linking ISSN: 10780998 NLM ISO Abbreviation: Inflamm Bowel Dis Subsets: MEDLINE
Database:	MEDLINE Ultimate

Be the first to leave a comment!